Balloon Infuser Market 2022
The global balloon infuser market is here to witness an irrevocable event in the coming years. Innovation in the form of digital tools is fashionable everywhere. Even though it is young people who engage with digital and social platforms, the geriatric population could benefit from engaging the services offered there. Thus, the exponential influx of e-business, online consultations, reservations and home delivery is likely to spill over to the business in the future.
The balloon infuser market is expected to reach US$2.5 billion in 2031, with elastomeric continuous infusion pumps holding maximum revenue share. According to a new report published by Persistence Market Research, the global balloon infuser market is valued at US$905.7 million in 2020 and is expected to grow at a CAGR of almost 9% during the forecast period (2021- 2031).
Get a free sample of this report @ https://www.persistencemarketresearch.com/samples/32517
The model of care delivery across the world is shifting towards evidence-based systems for better tracking of capital flows, patient progress, and reduced length of hospital stay. One of the most important requirements of evidence-based treatment is in the Acute Pain Service (APS).
Balloon infusers, being lightweight and the most economical in nature, are increasingly being adopted in hospitals and home care facilities. These are easy to use and can be monitored by patients and licensed caregivers. These are preferred over electronic pumps because they can deliver fluids at precise volumes, frequencies, and intervals.
Major pharmaceutical companies focus on manufacturing user-friendly balloon infusers with regulators and flow sensors for the accurate measurement of drug delivery rates. Moreover, some players, as part of their strategy to gain more market share, are launching balloon infusers with additional features.
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Baxter International Inc.
• Terumo Corporation
• Nipro Corporation
• Smith’s Medical
• Avanos Medical, Inc.
• Ambu A/S
• Pfm Medical Ag
• Daiken Medical Co., Ltd.
• Palex Medical SA
• Canack Technology Ltd.
• PROMECON GmbH.
• Halomedical Systems Ltd.
Methodology [email protected] https://www.persistencemarketresearch.com/methodology/32517
Key insights from market research
• Continuous flow balloon infusers are expected to contribute around 70% revenue share in the market by 2031.
• Among all applications, pain management segment is expected to grow at a CAGR of 10% by 2031. However, chemotherapy is also expected to be the next major segment as cancer is one of the leading diseases chronic and should maintain 1/3 market share.
• Among all end users, the hospital segment accounted for more than 40% market share in 2020.
• North America holds the highest share in the global balloon infuser market, while East Asia is the second leading region, owing to various technological advancements in balloon infusers.
• The United States holds a large share of global revenues and accounts for approximately 90% of North American market share.
“Rising number of chronic diseases, growing adoption of balloon infusers, ongoing COVID-19 pandemic, and technologically advanced products are factors that are expected to drive the market growth over the coming years,” says an analyst from Persistence Market Research.
Access the full report @ https://www.persistencemarketresearch.com/checkout/32517
Innovative product bundling strategies creating sustainable demand
Manufacturers of infuser bags are gradually focusing on bundling related accessories and IV medications to increase their market penetration. In this regard, reliance on direct sales visits is increasing in economies such as India and China.
Direct sales staff visits train the staff responsible for delivering medicines to patients. This reinforces the goodwill of the producers and the possibility of contractual agreements with the end user. Attractive and effective margin negotiations and pricing are planned strategies to drive future balloon infuser sales.
What does the report cover?
Persistence Market Research offers unique perspective and actionable insights into the Balloon Infuser market in its latest study, presenting a historical demand assessment from 2016 to 2020 and projections for 2021 to 2031.
The research study is based on the product (continuous flow balloon infusers and variable flow balloon infusers), the application (pain management, antibiotic therapy, antiviral therapy, chemotherapy and others) and the end user ( hospitals, outpatient surgery centers, home care facilities, specialty clinics and others), in seven key regions around the world.
Address – 305 Broadway, 7th Floor, New York, NY 10007 USA
Telephone in the United States – +1-646-568-7751
USA-Canada Toll Free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com
Persistence Market Research is here to provide businesses with a one stop solution when it comes to improving customer experience. It is committed to gathering appropriate feedback after going through personalized customer interactions to add value to the customer experience by acting as the “missing” link between “customer relationships” and “business results”. The best possible yields are guaranteed.
This press release was published on openPR.